LYNDHURST, N.J., Aug 08, 2005 /PRNewswire-FirstCall via COMTEX/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced today that its Board of Directors has
elected Jenne K. Britell, Ph.D., to serve as a Director, increasing the Board
to 11 members.
Dr. Britell, 63, is Chairman and CEO of Structured Ventures, Inc., a
private company which advises venture capital firms and financial institutions
in both U.S. and foreign markets. She has also been the Senior Advisor to
eBay and its PayPal subsidiary for financial services.
"I am delighted to welcome Jenne Britell to our Board," said Surya N.
Mohapatra, Ph.D., Chairman and Chief Executive Officer of Quest Diagnostics.
"Jenne has served global companies, both as a corporate officer and board
member, in the field of financial services. Her vast experience and valuable
international perspectives will complement an already strong, diverse and
independent Board."
Previously, Dr. Britell was a senior executive with GE Capital, most
recently as President of Global Mortgage and Commercial Banking and Executive
Vice President of Global Consumer Finance. Earlier, Dr. Britell was President
and CEO of GE Capital for Central and Eastern Europe, based in Vienna. During
that period, she also served as Chairman of the management or supervisory
boards of several GE-owned banks, including those in Poland, Hungary, the
Czech Republic and Romania. Prior to joining GE, she also held senior
positions at Citicorp and Republic New York Corporation.
Dr. Britell is also a Director of Aames Investment Corporation, Crown
Holdings, Inc. and Lincoln National Corporation.
Quest Diagnostics is the leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its national network of laboratories and patient
service centers, and provides interpretive consultation through its extensive
medical and scientific staff. Quest Diagnostics is a pioneer in developing
innovative new diagnostic tests and advanced healthcare information technology
solutions that help improve patient care. Additional company information is
available at: http://www.questdiagnostics.com .
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, competitive environment, changes in
government regulations, changing relationships with customers, payers,
suppliers and strategic partners and other factors described in the Quest
Diagnostics Incorporated 2004 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics Incorporated
Investors:
Joseph Manory
201-393-5030
Media:
Gary Samuels
201-393-5700,
both
of Quest Diagnostics Incorporated